Trials / Withdrawn
WithdrawnNCT00648674
A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers
A Prospective, Single-Site Study to Identify and Characterize the Molecular Mechanisms of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Organogenesis · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single site clinical study utilizing the novel technology of microarrays to identify and characterize the molecular mechanisms through which Apligraf promotes healing of venous leg ulcers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Apligraf | Applied at Day 0, possible re-application at Week 6 |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-04-01
- Last updated
- 2015-08-19
Source: ClinicalTrials.gov record NCT00648674. Inclusion in this directory is not an endorsement.